Vālenz, a leading innovator for solutions that reduce medical claim costs and promote quality healthcare, has recently expanded its strategic acumen by welcoming Colin Glen to the executive team. Glen is now Vice President of Business for Vālenz Assurance, which delivers solutions for assured compliance and payment integrity as part of the firm’s comprehensive health administrative ecosystem.
Having held leadership positions at such firms as Intelligent Medical Solutions, Oration, WhiteCloud Analytics and, most recently, Relias, Glen brings nearly 20 years’ experience to his new role.
“Throughout his career, Colin has excelled at serving the needs of the health industry with technology and data-driven solutions,” said Rob Gelb, Chief Revenue Officer at Valenz. “He has an in-depth understanding of our clients’ needs and how to address them with our innovative and uniquely comprehensive platform. We are thrilled to have him on the Valenz team.”
Glen is well-positioned to support the Valenz growth strategy – and that growth, he says, is a key component to smarter, better, faster healthcare. “We ensure the integrity of data for clients who rely on our coding, compliance and credentialing solutions, as well as for the Valenz ecosystem,” Glen explained. “Ultimately, our solutions positively affect our clients’ capacity to reduce costs while improving care quality and outcomes.”
For more information about the complete health administrative ecosystem or any of its core components available through Valenz, call 877-762-4455.
Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. More information is available online at valenzhealth.com. Valenz is backed by Great Point Partners. For more information about Valenz, visit www.valenzhealth.com or call (866) 762-4455.
About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading health care investment firm, currently with approximately $1.8 billion of equity capital currently under management and 28 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing health care companies. The private equity funds invest across all sectors of the health care industry with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Reach Great Point at (203) 971-3300 or www.gppfunds.com.